ST诺泰：取得《药品注册证书》

Group 1 - ST诺泰 announced the receipt of the drug registration certificate for Ipatasertib from the National Medical Products Administration [1] - The approval signifies a significant milestone for 江苏诺泰澳赛诺生物制药股份有限公司 in the pharmaceutical industry [1] Group 2 - The news highlights a shift in AI usage, with China surpassing the US in AI call volume, leading to a surge in various sectors in the A-share market [1] - A notable Wall Street analyst commented on China's computing power path, indicating a disruption of traditional perceptions [1]